スポンサーリンク
浜松医科大学 第3内科 | 論文
- 地固め療法後の急性骨髄性白血病に対する遺伝子組換え型ヒト顆粒球コロ二一刺激因子の二重盲検群間比較試験
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- ミコフェノール酸モフェチルの全身性エリテマトーデスにおける有用性の検討
- 地方病院における大量輸血対応体制の構築と血液の有効利用
- 糖鎖結合を利用したリガンドのラベルと非放射能性受容体定量法の確立
- 3次元マイクロアレイシステムによるK-rasコドン12の変異解析に関する基礎的検討
- 血液疾患患者におけるクレアチンキナーゼBB (CK-BB) アイソザイム活性およびCK-B mRNA発現量 : CK-BB著増を示した骨髄異型性症候群, 慢性骨髄性白血病症例を中心に
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- -P188- IMPAIRED PHOSPHOCREATINE SHUTTLE IN DIABETIC CARDIOMYOPATHY(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- 急性白血病に対するモノクローナル抗体療法
- 急性骨髄性白血病に対するanti-CD33療法--抗CD33療法の有用性 (第1土曜特集 造血器腫瘍のあらたな治療戦略) -- (新しい治療戦略のトピックス)